Recent developments in the study of pyrazinamide: An update

Denis A. Mitchison, Ying Zhang

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Pyrazinamide (PZA) is an unusual antituberculosis drug because its bactericidal activity increases as bacterial metabolism decreases, for instance in models of bacterial persistence, from the action of energy inhibitors, during hypoxic incubation and at low incubation temperatures. These characteristics make PZA particularly effective in killing persistent bacteria that other antibacterials fail to kill, and so make it an essential drug to be included in any current or new drug combination. This behaviour is explained by the Zhang model of PZA in which PZA is first deaminated to the active form of the drug pyrazinoic acid (POA) which enters the cell by passive pH-dependent diffusion but can only leave through an inefficient efflux pump which requires energy. If insufficient energy is available to drive its efflux, POA accumulates within the cell and is lethal. Weak acids, iron, oxidative stress, UV and DNA damage also increase PZA activity. Resistance to PZA is almost always due to mutations that occur widely distributed within the pncA gene that codes for pyrazinamidase involved in the conversion of the prodrug PZA to POA. We suggest increasing the cut-off concentration defining resistance in pH 6.0 medium and the use of the Brander test with high concentrations of nicotinamide in medium at normal pH for phenotype-based PZA susceptibility testing. Sequencing of pncA for mutations represents a rapid molecular test for detecting PZA resistance and avoids the problem of conventional phenotype-based PZA susceptibility testing.

Original languageEnglish (US)
Title of host publicationAntituberculosis Chemotherapy
EditorsPeter Donald, Paul Helden
Pages32-43
Number of pages12
DOIs
StatePublished - Sep 1 2011

Publication series

NameProgress in Respiratory Research
Volume40
ISSN (Print)1422-2140
ISSN (Electronic)1662-3932

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Fingerprint Dive into the research topics of 'Recent developments in the study of pyrazinamide: An update'. Together they form a unique fingerprint.

Cite this